Works matching DE "THROMBOPOIETIN"
Results: 565
Corrigendum: D-dencichine regulates thrombopoiesis by promoting megakaryocyte adhesion, migration and proplatelet formation.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
D-dencichine Regulates Thrombopoiesis by Promoting Megakaryocyte Adhesion, Migration and Proplatelet Formation.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2018.00297
- By:
- Publication type:
- Article
The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 9, p. 971, doi. 10.1038/nsmb.2099
- By:
- Publication type:
- Article
Improving pharmacological activities of thrombopoietin mimetic peptide by genetic fusion to albumin-binding domain.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 4, p. 439, doi. 10.1007/s10529-023-03345-3
- By:
- Publication type:
- Article
Functional expression of human serum albumin-tandem thrombopoietin mimetic peptide fusion protein as a novel thrombopoietin analog in Pichia pastoris.
- Published in:
- Biotechnology Letters, 2016, v. 38, n. 5, p. 779, doi. 10.1007/s10529-016-2049-8
- By:
- Publication type:
- Article
Effect of thrombopoietin on platelet counts and liver regeneration after partial hepatectomy in a rat model.
- Published in:
- Surgery Today, 2009, v. 39, n. 12, p. 1054, doi. 10.1007/s00595-008-4054-6
- By:
- Publication type:
- Article
肺癌化疗所致血小板减少症二级预防方案中重组人血小板生成素使用频次的优化
- Published in:
- Pharmaceutial Care & Research, 2022, v. 22, n. 1, p. 29, doi. 10.5428/pcar20220106
- By:
- Publication type:
- Article
海曲泊帕乙醇胺片联合环孢素 A 治疗难治性免疫性血小板减少症的 临床疗效及安全性.
- Published in:
- Progress in Modern Biomedicine, 2024, v. 24, n. 24, p. 4695, doi. 10.13241/j.cnki.pmb.2024.24.021
- By:
- Publication type:
- Article
ROMIPLOSTIM AND ELTROMBOPAG FOR IMMUNE THROMBOCYTOPENIA: METHODS FOR INDIRECT COMPARISON.
- Published in:
- International Journal of Technology Assessment in Health Care, 2012, v. 28, n. 3, p. 249, doi. 10.1017/S0266462312000414
- By:
- Publication type:
- Article
PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injury.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42443-0
- By:
- Publication type:
- Article
PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injury.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42443-0
- By:
- Publication type:
- Article
RETRACTED: Five Active Components Compatibility of Astragali Radix and Angelicae Sinensis Radix Protect Hematopoietic Function Against Cyclophosphamide-Induced Injury in Mice and t-BHP-Induced Injury in HSCs.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2019.00936
- By:
- Publication type:
- Article
Thrombopoietin and liver diseases.
- Published in:
- Journal of Gastroenterology & Hepatology, 2000, v. 15, n. 6, p. 579, doi. 10.1046/j.1440-1746.2000.02189.x
- By:
- Publication type:
- Article
Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis.
- Published in:
- Journal of Gastroenterology & Hepatology, 1998, v. 13, n. 9, p. 907
- By:
- Publication type:
- Article
Review article: thrombocytopenia in chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 26, p. 5, doi. 10.1111/j.1365-2036.2007.03510.x
- By:
- Publication type:
- Article
Successful Management of Immune Thrombocytopenia Presenting with Lethal Alveolar Hemorrhage.
- Published in:
- Case Reports in Hematology, 2019, p. 1, doi. 10.1155/2019/5170282
- By:
- Publication type:
- Article
Thrombopoietin mimetics for systemic lupus erythematosus with antiphospholipid antibodies should be discussed separately.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Thrombopoietin levels in systemic lupus erythematosus are linked to inflammatory cytokines, but unrelated to thrombocytopenia or thrombosis.
- Published in:
- Lupus, 2015, v. 24, n. 1, p. 18, doi. 10.1177/0961203314547796
- By:
- Publication type:
- Article
Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus.
- Published in:
- Lupus, 2002, v. 11, n. 4, p. 221, doi. 10.1191/0961203302lu177oa
- By:
- Publication type:
- Article
Thrombopoietin receptor agonist romiplostim in refractory thrombocytopenia as a bridging therapy to the second allogeneic stem cell transplantation.
- Published in:
- Lijecnicki Vjesnik, 2019, v. 141, p. 38
- By:
- Publication type:
- Article
Ex vivo stem cell culture.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 8, p. 738, doi. 10.1038/11644
- By:
- Publication type:
- Article
Thrombopoietin as Biomarker and Mediator of Cardiovascular Damage in Critical Diseases.
- Published in:
- Mediators of Inflammation, 2012, v. 2012, p. 1, doi. 10.1155/2012/390892
- By:
- Publication type:
- Article
Thrombopoietin protects mice from mortality and myelosuppression following high-dose irradiation: importance of time scheduling.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2002, v. 80, n. 7, p. 717, doi. 10.1139/y02-090
- By:
- Publication type:
- Article
International Forum: 3.
- Published in:
- 2005
- By:
- Publication type:
- Other
International Forum: 4.
- Published in:
- 2005
- By:
- Publication type:
- Other
The (patho)physiology of megakaryocytopoiesis: from thrombopoietin in diagnostics and therapy to ex vivo generated cellular products.
- Published in:
- Vox Sanguinis, 2004, v. 87, p. 52, doi. 10.1111/j.1741-6892.2004.00500.x
- By:
- Publication type:
- Article
Kinetics of CFU-Mk after automated plateletpheresis.
- Published in:
- Vox Sanguinis, 2001, v. 81, n. 3, p. 167, doi. 10.1046/j.0042-9007.2001.00096.x
- By:
- Publication type:
- Article
Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
- Published in:
- British Journal of Cancer, 2015, v. 113, n. 5, p. 756, doi. 10.1038/bjc.2015.227
- By:
- Publication type:
- Article
Optimizing Optimata.
- Published in:
- Bio-IT World, 2005, v. 4, n. 11, p. 46
- By:
- Publication type:
- Article
Effect of doxycycline-regulated calnexin and calreticulin expression on specific thrombopoietin productivity of recombinant chinese hamster ovary cells.
- Published in:
- Biotechnology & Bioengineering, 2004, v. 85, n. 5, p. 539, doi. 10.1002/bit.10919
- By:
- Publication type:
- Article
Thrombopoietin Protects Cardiomyocytes from Iron-Overload Induced Oxidative Stress and Mitochondrial Injury.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2015, v. 36, n. 5, p. 2063, doi. 10.1159/000430173
- By:
- Publication type:
- Article
Salicylate Inhibits Thrombopoiesis in Rat Megakaryocytes by Changing the Membrane Micro-Architecture.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2015, v. 35, n. 6, p. 2371, doi. 10.1159/000374039
- By:
- Publication type:
- Article
Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1340908
- By:
- Publication type:
- Article
Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 321, doi. 10.1111/j.1365-2125.2011.03972.x
- By:
- Publication type:
- Article
Romiplostim as a treatment for immune thrombocytopenia: a review.
- Published in:
- Journal of Blood Medicine, 2015, v. 6, p. 37, doi. 10.2147/JBM.S47240
- By:
- Publication type:
- Article
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 12, p. 1834, doi. 10.1038/leu.2011.161
- By:
- Publication type:
- Article
The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The ‘GGCC’ haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 10, p. 1924, doi. 10.1038/leu.2009.110
- By:
- Publication type:
- Article
MPL<sup>W515L</sup> mutation in acute megakaryoblastic leukaemia.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 5, p. 852, doi. 10.1038/leu.2008.371
- By:
- Publication type:
- Article
Aberrant signal transduction pathways in myeloproliferative neoplasms.
- Published in:
- Leukemia (08876924), 2008, v. 22, p. P121
- By:
- Publication type:
- Article
Aberrant signal transduction pathways in myeloproliferative neoplasms.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 8, p. 1551, doi. 10.1038/leu.2008.115
- By:
- Publication type:
- Article
New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G<sub>1</sub>/S-phase transition.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 8, p. 1557, doi. 10.1038/leu.2008.137
- By:
- Publication type:
- Article
hNUDC promotes the cell proliferation and differentiation in a leukemic cell line via activation of the thrombopoietin receptor (Mpl).
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 5, p. 1018, doi. 10.1038/leu.2008.20
- By:
- Publication type:
- Article
The thrombopoietin mimetic JNJ-26366821 increases megakaryopoiesis without affecting malignant myeloid proliferation.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 10, p. 2453, doi. 10.1080/10428194.2020.1775213
- By:
- Publication type:
- Article
TPO-mimetics for chemotherapy-induced thrombocytopenia: timing matters.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 12, p. 2763, doi. 10.1080/10428194.2018.1482545
- By:
- Publication type:
- Article
Recombinant human thrombopoietin (rh-TPO) for the prevention of severe thrombocytopenia induced by high-dose cytarabine: a prospective, randomized, self-controlled study.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 12, p. 2821, doi. 10.1080/10428194.2018.1459605
- By:
- Publication type:
- Article
Supportive care for thrombocytopenia in patients receiving treatment for myelodysplasia: a challenge for the future.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.
- Published in:
- Leukemia & Lymphoma, 2011, v. 52, n. 4, p. 724, doi. 10.3109/10428194.2010.551794
- By:
- Publication type:
- Article